TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23911077

Group type: EXPERIMENTAL
Intervention: Upper limb task specific repetitive training (TSRT) guided by a robotic orthosis
Number of subjects: 15

Group type: COMPARATOR
Intervention: Upper limb task specific repetitive training (TSRT) guided by a physical therapist
Number of subjects: 15
Study: 21822018

Group type: EXPERIMENTAL
Intervention: Magnolia gum
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Xylitol gum
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control gum
Number of subjects: 120
Study: 19491796

Group type: EXPERIMENTAL
Intervention: Aqua Maris nasal spray (thrice daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard therapy alone (Control)
Number of subjects: 50
Study: 17955784

Group type: EXPERIMENTAL
Intervention: Donepezil, Galantamine, Rivastigmine (acetylcholinesterase inhibitors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Memantine (glutamate antagonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of acetylcholinesterase inhibitors or memantine
Number of subjects: 0
Study: 12460525

Group type: EXPERIMENTAL
Intervention: Multifaceted, practice‐based intervention involving audit, feedback, and academic detailing
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 10601178

Group type: EXPERIMENTAL
Intervention: DHEA (150 mg/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: DHEA (50 mg acute ingestion)
Number of subjects: 29
Study: 8554931

Group type: EXPERIMENTAL
Intervention: Endothelin-1 (5 pmol min-1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Big endothelin-1 (50 pmol min-1)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sodium chloride (0.9%; w/v)
Number of subjects: 6
Study: 1951544

Group type: EXPERIMENTAL
Intervention: Home uterine activity monitoring (monitored group)
Number of subjects: 377

Group type: COMPARATOR
Intervention: High-risk prenatal care alone (not monitored group)
Number of subjects: 377
Study: 7032489

Group type: EXPERIMENTAL
Intervention: Haemorrhoidectomy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Rubber band ligation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Maximal anal dilatation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Injection
Number of subjects: 120
Study: 31686175

Group type: EXPERIMENTAL
Intervention: Nicotine (7 mg/24 h, transdermally) and galantamine (4 mg, p.o.) combined
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nicotine alone (7 mg/24 h, transdermally)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Galantamine alone (4 mg, p.o.)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Double placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Galantamine (4 mg, p.o.)
Number of subjects: 26
Study: 30808132

Group type: EXPERIMENTAL
Intervention: Canalith repositioning procedure based on results of supine roll test
Number of subjects: 100

Group type: COMPARATOR
Intervention: Canalith repositioning procedure based on results of lean nystagmus and sitting to supine positioning nystagmus
Number of subjects: 100
Study: 28251402

Group type: EXPERIMENTAL
Intervention: BRJ (140 ml concentrated nitrate-rich beetroot juice, 12.5 mmol nitrate)
Number of subjects: 8

Group type: COMPARATOR
Intervention: PLA (nitrate-deplete beetroot juice, 0.01 mmol nitrate)
Number of subjects: 8
Study: 26198373

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1000 mg/m² plus vinorelbine 60 mg/m²
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Vinorelbine doses per kg LBM
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Dose reduction and/or stop of treatment
Number of subjects: 153
Study: 23312874

Group type: EXPERIMENTAL
Intervention: Desires for Alcohol Questionnaire (DAQ‐6)
Number of subjects: 826
Study: 21823413

Group type: EXPERIMENTAL
Intervention: Acupuncture (body acupuncture, scalp acupuncture, electric acupuncture)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Routine rehabilitation training
Number of subjects: 148
Study: 18240879

Group type: EXPERIMENTAL
Intervention: Entecavir
Number of subjects: 709

Group type: COMPARATOR
Intervention: Lamivudine
Number of subjects: 709
Study: 16531896

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (10,000 IU beta-carotene, 200 IU alpha-tocopherol acetate, 250 mg ascorbic acid, 50 microg selenium, 15 mg zinc)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both groups (Antioxidant and Placebo)
Number of subjects: 17
Study: 15193678

Group type: EXPERIMENTAL
Intervention: Fondaparinux 2.5 mg once daily
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Fondaparinux 4 mg once daily
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Fondaparinux 8 mg once daily
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Fondaparinux 12 mg once daily
Number of subjects: 929

Group type: COMPARATOR
Intervention: Enoxaparin 1 mg/kg twice daily
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Fondaparinux 2.5 mg once daily (per-protocol analysis)
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Fondaparinux 4 mg once daily (per-protocol analysis)
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Fondaparinux 8 mg once daily (per-protocol analysis)
Number of subjects: 929

Group type: EXPERIMENTAL
Intervention: Fondaparinux 12 mg once daily (per-protocol analysis)
Number of subjects: 929

Group type: COMPARATOR
Intervention: Enoxaparin 1 mg/kg twice daily (per-protocol analysis)
Number of subjects: 929
Study: 10411250

Group type: EXPERIMENTAL
Intervention: Low-dose methyl prednisolone sodium succinate (MPSS) 1 mg/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low-dose methyl prednisolone sodium succinate (MPSS)
Number of subjects: 20
Study: 7550814

Group type: EXPERIMENTAL
Intervention: Trivalent subvirion influenza virus vaccine
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Myringotomy tubes
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Influenza vaccine
Number of subjects: 186
Study: 2127561

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Mianserin
Number of subjects: 63
Study: 6990861

Group type: EXPERIMENTAL
Intervention: Cimetidine (1.0 g daily) for four weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cimetidine (1.0 g daily)
Number of subjects: 50
Study: 30215583

Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine (PPV23)
Number of subjects: 1760

Group type: COMPARATOR
Intervention: Control commercial vaccine
Number of subjects: 1760
Study: 28929865

Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography (LDCT) screening
Number of subjects: 26722

Group type: COMPARATOR
Intervention: Chest radiographs
Number of subjects: 26722
Study: 27188898

Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control oil (vegetable oil)
Number of subjects: 19
Study: 24515581

Group type: EXPERIMENTAL
Intervention: Patient education regarding family health history (FHH) collection
Number of subjects: 43
Study: 22763465

Group type: COMPARATOR
Intervention: Anastrozole plus placebo (A + P)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Anastrozole plus risedronate (A + R)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Anastrozole (A) alone
Number of subjects: 119
Study: 20712051

Group type: EXPERIMENTAL
Intervention: Cap-assisted colonoscopy (CAC)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard colonoscopy (SC)
Number of subjects: 400
Study: 17647038

Group type: EXPERIMENTAL
Intervention: Dietary counseling and probiotics (Lactobacillus GG and Bifidobacterium lactis Bb12; n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dietary counseling with probiotics (n = 10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dietary counseling with placebo (n = 12)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo alone (n = 8)
Number of subjects: 30
Study: 16336882

Group type: EXPERIMENTAL
Intervention: Botox Cosmetic 20 U
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dysport 50 U
Number of subjects: 0
Study: 12164449

Group type: COMPARATOR
Intervention: Epicardial wire placed at the lateral wall of the right atrium (Group 2)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Wire placed at Bachmann's bundle (Group 3)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group (Group 1)
Number of subjects: 161
Study: 10583317

Group type: EXPERIMENTAL
Intervention: Lysine vasopressin (LVP) administration with minimal dose of GH-RH (0.035 microg/kg BW)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lysine vasopressin (LVP) administration with maximal dose of GH-RH (100 microg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lysine vasopressin (LVP) administration with arginine (30 g over 30 min)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lysine vasopressin (LVP) administration with clonidine (150 microg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal saline administration
Number of subjects: 20
Study: 7589051

Group type: EXPERIMENTAL
Intervention: Sustained-release diltiazem LP 300 mg
Number of subjects: 2
Study: 29161998

Group type: EXPERIMENTAL
Intervention: MMT plus CRT (Cognitive Rehabilitation Treatment) for two months
Number of subjects: 120

Group type: COMPARATOR
Intervention: MMT plus control intervention
Number of subjects: 120
Study: 26923256

Group type: EXPERIMENTAL
Intervention: Donepezil 23 mg
Number of subjects: 197

Group type: COMPARATOR
Intervention: Donepezil 10 mg
Number of subjects: 197
Study: 25530384

Group type: COMPARATOR
Intervention: 4 mg doxazosin XL
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: 8 mg doxazosin XL
Number of subjects: 162

Group type: COMPARATOR
Intervention: 4 mg doxazosin XL (group 1b)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: 8 mg doxazosin XL (group 1b)
Number of subjects: 162
Study: 22790267

Group type: EXPERIMENTAL
Intervention: Real-time quantitative polymerase chain reaction using SYBR Green I dye for detecting ABO chimerism at nucleotide polymorphism sites 261, 467, and 803.
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Real-time quantitative polymerase chain reaction for detecting ABO chimerism.
Number of subjects: 76
Study: 21691253

Group type: EXPERIMENTAL
Intervention: Fish Oil (FO)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Sunflower Oil (SO)
Number of subjects: 154
Study: 19446151

Group type: EXPERIMENTAL
Intervention: Dispersible tablet formulation of arbidol 200 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Branded capsule formulation of arbidol 200 mg
Number of subjects: 20
Study: 17224848

Group type: EXPERIMENTAL
Intervention: Tablet formulation of lopinavir/ritonavir (800/200 mg or 400/100 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tablet formulation of lopinavir/ritonavir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Soft-gelatin capsule (SGC) formulation of lopinavir/ritonavir
Number of subjects: 0
Study: 15042010

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (400 microg every 4 hours for 24 hours)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (400 microg every 4 hours for 24 hours)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Intra-amniotic PGF(2alpha) (40 mg followed by oxytocin infusion)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Intra-amniotic PGF(2alpha)
Number of subjects: 217
Study: 11722960

Group type: EXPERIMENTAL
Intervention: Phylloquinone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dihydrophylloquinone
Number of subjects: 15
Study: 9137791

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy to 54 Gy to the breast (XRT group)
Number of subjects: 381

Group type: COMPARATOR
Intervention: Surgery alone (non XRT group)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Comedo cancer
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Lobular cancers
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Mammographic appearance as circular/oval shaped density
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Mammographic appearance as a stellate lesion with microcalcifications
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Comedo cancers (multivariate analysis)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Mammographic appearance of a stellate lesion with microcalcifications (multivariate analysis)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Patients > 60 years of age without comedo or lobular cancers
Number of subjects: 381
Study: 8192104

Group type: EXPERIMENTAL
Intervention: Acivicin 60 mg/m2 as a continuous intravenous infusion over 72 hours, repeated every 28 days
Number of subjects: 82

Group type: COMPARATOR
Intervention: Etoposide 120 mg/m2 daily on days 1, 2, and 3 and cisplatin 60 mg/m2 intravenously on day 1, repeated every 28 days
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Acivicin
Number of subjects: 82
Study: 3300325

Group type: EXPERIMENTAL
Intervention: Antimicrobial therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Antimicrobial therapy and No therapy
Number of subjects: 50
Study: 29235967

Group type: EXPERIMENTAL
Intervention: Alternating working postures
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sitting posture
Number of subjects: 45
Study: 27612446

Group type: EXPERIMENTAL
Intervention: Dialysis Optimal Health Program (DOHP)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 96
Study: 23822820

Group type: EXPERIMENTAL
Intervention: Motivational interviewing training for pharmacists
Number of subjects: 542
Study: 22020244

Group type: EXPERIMENTAL
Intervention: Pre-hospital cooling using a rapid infusion of up to two litres ice-cold Hartmann's solution (82 patients)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Cooling after hospital admission (81 patients)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Pre-hospital cooling in patients with a cardiac cause of arrest (47 patients)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Hospital cooled patients with a cardiac cause of arrest (43 patients)
Number of subjects: 163
Study: 20810095

Group type: EXPERIMENTAL
Intervention: Mechanical shaver debridement (MSD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Radiofrequency-based chondroplasty (RFC)
Number of subjects: 60
Study: 19717804

Group type: EXPERIMENTAL
Intervention: Graduate Record Exam verbal score (GRE-V)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Undergraduate grade point average (UGPA)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Underrepresented minority status (URMS)
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: GRE-V, UGPA, and prior graduate degree
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: GRE-V
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Course Mastery
Number of subjects: 235
Study: 15681958

Group type: EXPERIMENTAL
Intervention: S-Caine Patch
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo Patch
Number of subjects: 64
Study: 12958723

Group type: EXPERIMENTAL
Intervention: Anticoagulation group (Group A) - Heparin intravenously with target aPTT 50-70 seconds
Number of subjects: 153

Group type: COMPARATOR
Intervention: Non-anticoagulation group (Group B) - No intravenous heparin
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Anticoagulation group (Group A)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Non-anticoagulation group (Group B)
Number of subjects: 153
Study: 10543590

Group type: EXPERIMENTAL
Intervention: Arthroscopic suture repair
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Arthroscopic Bankart repair with absorbable polyglyconate tack
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Open capsular shift with repair of the Bankart lesion
Number of subjects: 56
Study: 8762769

Group type: EXPERIMENTAL
Intervention: Plastic spectacle frames (7 frames)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Metal spectacle frames (3 frames)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Theoretical visual field defects calculation
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: General findings regarding spectacle frames
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Frames allowing adequate vision at night
Number of subjects: 2
Study: 1990794

Group type: EXPERIMENTAL
Intervention: 10 mg of intravenous verapamil
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 10 ml of 10% intravenous calcium chloride followed by 10 mg of intravenous verapamil
Number of subjects: 8

Group type: COMPARATOR
Intervention: 10 ml of 0.9% intravenous sodium chloride followed by 10 mg of intravenous verapamil
Number of subjects: 8

Group type: COMPARATOR
Intervention: 10 ml of 10% intravenous calcium chloride followed by 4 ml of 0.9% intravenous sodium chloride
Number of subjects: 8
Study: 6848891

Group type: EXPERIMENTAL
Intervention: Thymectomy with azathioprine therapy for 1 year
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Thymectomy without azathioprine therapy for 1 year
Number of subjects: 35
Study: 31267524

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Random skin biopsy combined with imaging
Number of subjects: 42
Study: 28850021

Group type: EXPERIMENTAL
Intervention: TCZ (Tocilizumab)
Number of subjects: 741
Study: 26585832

Group type: EXPERIMENTAL
Intervention: RIPC-RIPostC
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control
Number of subjects: 65
Study: 24405800

Group type: EXPERIMENTAL
Intervention: Dabigatran (Pradaxa)
Number of subjects: 92
Study: 22196293

Group type: EXPERIMENTAL
Intervention: 10 mg dexamethasone via iontophoresis
Number of subjects: 82

Group type: COMPARATOR
Intervention: 10 mg dexamethasone injection
Number of subjects: 82

Group type: COMPARATOR
Intervention: 10 mg triamcinolone injection
Number of subjects: 82
Study: 20303788

Group type: EXPERIMENTAL
Intervention: Omega-3 fish oil supplementation (2.1 g/day) for 90 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no omega-3 supplementation)
Number of subjects: 40
Study: 17673448

Group type: EXPERIMENTAL
Intervention: Dual-antiplatelet therapy (aspirin plus clopidogrel)
Number of subjects: 2289

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 2289
Study: 14730323

Group type: EXPERIMENTAL
Intervention: Immediate balloon angioplasty (PTRA)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Drug therapy followed by angioplasty after 3 months (Med-PTRA)
Number of subjects: 106
Study: 11377642

Group type: EXPERIMENTAL
Intervention: New model of antenatal care (median of 5 visits)
Number of subjects: 25526

Group type: COMPARATOR
Intervention: Standard model of antenatal care (median of 8 visits)
Number of subjects: 25526
Study: 9598265

Group type: EXPERIMENTAL
Intervention: Modified Macintosh blade
Number of subjects: 30
Study: 7893284

Group type: EXPERIMENTAL
Intervention: bezafibrate 200 mg 3 times a day
Number of subjects: 27

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study: 3058130

Group type: EXPERIMENTAL
Intervention: Cyclobenzaprine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 30777027

Group type: EXPERIMENTAL
Intervention: Continuous anterior QL block (CQLB)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (PCIA)
Number of subjects: 63
Study: 28978520

Group type: EXPERIMENTAL
Intervention: Mnemonic-use method (MUM)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Self-study method (STMM)
Number of subjects: 29
Study: 25738345

Group type: EXPERIMENTAL
Intervention: Coronally advanced flap with connective tissue graft (CAF + CTG)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Coronally advanced flap alone (CAF)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both treatments (CAF + CTG and CAF)
Number of subjects: 25
Study: 24209458

Group type: EXPERIMENTAL
Intervention: Early Start Group (ESG) exercise program for 1 h, three days/week, for 48 weeks.
Number of subjects: 31

Group type: COMPARATOR
Intervention: Delayed Start Group (DSG) exercise program for 1 h, three days/week, from weeks 24-48.
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Early Start Group (ESG) exercise program.
Number of subjects: 31

Group type: COMPARATOR
Intervention: Delayed Start Group (DSG) exercise program.
Number of subjects: 31
Study: 22571552

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 30
Study: 19116603

Group type: EXPERIMENTAL
Intervention: MenACWY-CRM(+) (with adjuvant)
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: MenACWY-CRM(‐) (without adjuvant)
Number of subjects: 524

Group type: COMPARATOR
Intervention: MPSV4 (licensed unconjugated quadrivalent polysaccharide vaccine)
Number of subjects: 524
Study: 18175550

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/day
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 54
Study: 15022127

Group type: EXPERIMENTAL
Intervention: HaloLite Paediatric Nebulizer (HPN)
Number of subjects: 14

Group type: COMPARATOR
Intervention: pressurized metered dose inhaler and valved holding chamber (pMDI VHC)
Number of subjects: 14
Study: 11533570

Group type: COMPARATOR
Intervention: Step aerobics
Number of subjects: 45

Group type: COMPARATOR
Intervention: Aerobic dancing
Number of subjects: 45
Study: 9661564

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cuffed Oropharyngeal Airway (COPA)
Number of subjects: 120
Study: 7633110

Group type: EXPERIMENTAL
Intervention: ECG-triggered turbo spin-echo (TSE)
Number of subjects: 22

Group type: COMPARATOR
Intervention: ECG-triggered conventional spin-echo (CSE)
Number of subjects: 22

Group type: COMPARATOR
Intervention: nontriggered turbo spin-echo (TSE)
Number of subjects: 22
Study: 2378237

Group type: EXPERIMENTAL
Intervention: Reflective blanket
Number of subjects: 40

Group type: COMPARATOR
Intervention: Warmed cotton blanket
Number of subjects: 40